Hepatitis B - Versionsgeschichte

Fmrauch am 25. November 2025 um 01:54 Uhr

2025-11-25T01:54:08Z

← Nächstältere Version		Version vom 25. November 2025, 01:54 Uhr
Zeile 1:		Zeile 1:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[~~Viren\|~~Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, gilt Hepatitis B weltweit als eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, gilt Hepatitis B weltweit als eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>

	Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland war in den 1980er Jahren bei 0,1 - 0,5% aller allgemeinen [[Krankenhaus]]patienten das Virus nachweisbar.<ref>F. Deinhardt in ''Lehrbuch der Medizinischen Mikrobiologie'', 6. Auflage 1988, Gustav Fischer Verlag Stuttgart, Seite 669</ref> Infolge verbesserter [[Hygiene]]standards gab es 2000–2018 weniger als 5000 Erkrankungsfälle pro Jahr; seitdem sind die Fallzahlen jedoch wieder steigend.		Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland war in den 1980er Jahren bei 0,1 - 0,5% aller allgemeinen [[Krankenhaus]]patienten das Virus nachweisbar.<ref>F. Deinhardt in ''Lehrbuch der Medizinischen Mikrobiologie'', 6. Auflage 1988, Gustav Fischer Verlag Stuttgart, Seite 669</ref> Infolge verbesserter [[Hygiene]]standards gab es 2000–2018 weniger als 5000 Erkrankungsfälle pro Jahr; seitdem sind die Fallzahlen jedoch wieder steigend.

Fmrauch am 22. November 2020 um 23:47 Uhr

2020-11-22T23:47:14Z

← Nächstältere Version		Version vom 22. November 2020, 23:47 Uhr
Zeile 1:		Zeile 1:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ~~ist die~~ Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, gilt Hepatitis B weltweit als eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>

	Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland war in den 1980er Jahren bei 0,1 - 0,5% aller allgemeinen [[Krankenhaus]]patienten das Virus nachweisbar.<ref>F. Deinhardt in ''Lehrbuch der Medizinischen Mikrobiologie'', 6. Auflage 1988, Gustav Fischer Verlag Stuttgart, Seite 669</ref> Infolge verbesserter [[Hygiene]]standards gab es 2000–2018 weniger als 5000 Erkrankungsfälle pro Jahr; seitdem sind die Fallzahlen jedoch wieder steigend.		Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland war in den 1980er Jahren bei 0,1 - 0,5% aller allgemeinen [[Krankenhaus]]patienten das Virus nachweisbar.<ref>F. Deinhardt in ''Lehrbuch der Medizinischen Mikrobiologie'', 6. Auflage 1988, Gustav Fischer Verlag Stuttgart, Seite 669</ref> Infolge verbesserter [[Hygiene]]standards gab es 2000–2018 weniger als 5000 Erkrankungsfälle pro Jahr; seitdem sind die Fallzahlen jedoch wieder steigend.

Fmrauch: erl.

2020-11-22T23:24:52Z

erl.

← Nächstältere Version		Version vom 22. November 2020, 23:24 Uhr
Zeile 1:		Zeile 1:
	~~{{Inuse}}~~

	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>

Fmrauch: Zahlen mit Quelle

2020-11-22T23:21:13Z

Zahlen mit Quelle

← Nächstältere Version		Version vom 22. November 2020, 23:21 Uhr
Zeile 3:		Zeile 3:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>

	Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland gab es 2000–2018 weniger als 5000 ~~Fälle~~ pro Jahr.		Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland war in den 1980er Jahren bei 0,1 - 0,5% aller allgemeinen [[Krankenhaus]]patienten das Virus nachweisbar.<ref>F. Deinhardt in ''Lehrbuch der Medizinischen Mikrobiologie'', 6. Auflage 1988, Gustav Fischer Verlag Stuttgart, Seite 669</ref> Infolge verbesserter [[Hygiene]]standards gab es 2000–2018 weniger als 5000 Erkrankungsfälle pro Jahr; seitdem sind die Fallzahlen jedoch wieder steigend.
	== Bibliographie ==		== Bibliographie ==
	<references />		<references />

Fmrauch: Zahlen zur Prüfung

2020-11-22T23:11:23Z

Zahlen zur Prüfung

← Nächstältere Version		Version vom 22. November 2020, 23:11 Uhr
Zeile 1:		Zeile 1:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en~~. Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden~~. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		{{Inuse}}

			Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>

			Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. In Deutschland gab es 2000–2018 weniger als 5000 Fälle pro Jahr.
	== Bibliographie ==		== Bibliographie ==
	<references />		<references />

Fmrauch: kann nicht sein, die wurden alle getestet?

2020-11-22T23:02:12Z

kann nicht sein, die wurden alle getestet?

← Nächstältere Version		Version vom 22. November 2020, 23:02 Uhr
Zeile 1:		Zeile 1:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Bei ~~etwa~~ einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] ~~nachweisbar~~. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Bei schätzungsweise einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] vorhanden. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>
	== Bibliographie ==		== Bibliographie ==
	<references />		<references />

Fmrauch: fraglich

2020-11-22T23:01:05Z

fraglich

← Nächstältere Version		Version vom 22. November 2020, 23:01 Uhr
Zeile 1:		Zeile 1:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Bei etwa einem Drittel der Weltbevölkerung sind als Zeichen einer ~~ausgeheilten HBV-~~Infektion spezifische [[Antikörper]] nachweisbar. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Bei etwa einem Drittel der Weltbevölkerung sind als Zeichen einer [[Infektion]] spezifische [[Antikörper]] nachweisbar. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>
	== Bibliographie ==		== Bibliographie ==
	<references />		<references />

Fmrauch am 22. November 2020 um 22:59 Uhr

2020-11-22T22:59:55Z

← Nächstältere Version		Version vom 22. November 2020, 22:59 Uhr
Zeile 1:		Zeile 1:
	Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] ~~(HBV)~~ verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Bei etwa einem Drittel der Weltbevölkerung sind als Zeichen einer ausgeheilten HBV-Infektion spezifische [[Antikörper]] nachweisbar. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>		Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren\|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis B weltweit eine der häufigsten [[Virusinfektion]]en. Bei etwa einem Drittel der Weltbevölkerung sind als Zeichen einer ausgeheilten HBV-Infektion spezifische [[Antikörper]] nachweisbar. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>
	== Bibliographie ==		== Bibliographie ==
	<references />		<references />

Fmrauch: Einleitung

2020-11-22T20:39:57Z

Einleitung

@@ Zeile 1: / Zeile 1: @@
-[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]
+Die '''Hepatitis B''' (früher auch ''Serumhepatitis'') ist eine von dem [[Hepatitis-B-Virus]] (HBV) verursachte [[Infektionskrankheit]] der [[Leber]], die häufig akut (85–90 %), gelegentlich auch chronisch verläuft. Mit etwa 350 Millionen Menschen, in deren Blut das [[Viren|Virus]] nachweisbar ist und bei denen somit das Virus dauerhaft als [[Infektionsquelle]] präsent ist, ist die Hepatitis&nbsp;B weltweit eine der häufigsten [[Virusinfektion]]en. Bei etwa einem Drittel der Weltbevölkerung sind als Zeichen einer ausgeheilten HBV-Infektion spezifische [[Antikörper]] nachweisbar. Die freien Übersichtsartikel zeigen 9 Jahre Forschungsgeschichte.<ref name="PMID19208509">Antiviral therapy for hepatitis B virus associated hepatic failure. Hepatobiliary Pancreat Dis Int 8(1):17-24 (2009) PMID 19208509 </ref><ref name="PMID18842489">Hepatitis B virus genotypes: an overview. Hepatobiliary Pancreat Dis Int 7(5):457-64 (2008) PMID 18842489 </ref><ref name="PMID16911930">Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5(3):350-9 (2006) PMID 16911930 </ref><ref name="PMID19399811">Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21 (2009) PMID 19399811 </ref><ref name="PMID6328774">Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med 140(5):754-62 (1984) PMID 6328774 </ref><ref name="PMID664630">Specialty conference: Chronic hepatitis B. West J Med 128(4):305-17 (1978) PMID 664630 </ref><ref name="PMID20135728">Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis. World J Gastroenterol 16(6):770-7 (2010) PMID 20135728 </ref><ref name="PMID19575488">Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 15(25):3099-105 (2009) PMID 19575488 </ref><ref name="PMID19152446">DNA-guided hepatitis B treatment, viral load is essential, but not sufficient. World J Gastroenterol 15(4):423-30 (2009) PMID 19152446 </ref><ref name="PMID17206760">Antiviral therapy and resistance with hepatitis B virus infection. World J Gastroenterol 13(1):125-40 (2007) PMID 17206760 </ref><ref name="PMID17206757">Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13(1):82-90 (2007) PMID 17206757 </ref><ref name="PMID17206755">Hepatitis B virus morphogenesis. World J Gastroenterol 13(1):65-73 (2007) PMID 17206755 </ref><ref name="PMID17206754">Hepatitis B virus replication. World J Gastroenterol 13(1):48-64 (2007) PMID 17206754 </ref><ref name="PMID17206753">Intracellular transport of hepatitis B virus. World J Gastroenterol 13(1):39-47 (2007) PMID 17206753 </ref><ref name="PMID17206752">Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22-38 (2007) PMID 17206752 </ref><ref name="PMID17206751">Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14-21 (2007) PMID 17206751 </ref><ref name="PMID17596850">Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46(1):254-65 (2007) PMID 17596850 </ref><ref name="PMID17393513">Management of hepatitis B: summary of a clinical research workshop. Hepatology 45(4):1056-75 (2007) PMID 17393513 </ref><ref name="PMID17256718">Chronic hepatitis B. Hepatology 45(2):507-39 (2007) PMID 17256718 </ref><ref name="PMID16447285">Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43(2 Suppl 1):S173-81 (2006) PMID 16447285 </ref><ref name="PMID15382157">Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection? Hepatology 40(4):790-2 (2004) PMID 15382157 </ref><ref name="PMID14578844">Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38(5):1075-86 (2003) PMID 14578844 </ref><ref name="PMID12939579">New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B. Hepatology 38(3):545-53 (2003) PMID 12939579 </ref><ref name="PMID12829979">Kinetics of the immune response during HBV and HCV infection. Hepatology 38(1):4-13 (2003) PMID 12829979 </ref><ref name="PMID12774009">Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature. Hepatology 37(6):1309-19 (2003) PMID 12774009 </ref><ref name="PMID12447854">Revisiting the cytopathic effect of hepatitis B virus infection. Hepatology 36(6):1327-9 (2002) PMID 12447854 </ref><ref name="PMID11981779">Clinical significance of hepatitis B virus genotypes. Hepatology 35(5):1274-6 (2002) PMID 11981779 </ref><ref name="PMID11732013">Chronic hepatitis B. Hepatology 34(6):1225-41 (2001) PMID 11732013 </ref><ref name="PMID11584355">Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34(4 Pt 1):617-24 (2001) PMID 11584355 </ref><ref name="PMID1968522">Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 37(2):663-76 (1990) PMID 1968522 </ref>
 == Bibliographie ==
 <references />
 {{PPA-Kupfer}}

Fmrauch am 22. November 2020 um 20:34 Uhr

2020-11-22T20:34:38Z

← Nächstältere Version		Version vom 22. November 2020, 20:34 Uhr
Zeile 49:		Zeile 49:
	<references />		<references />

			{{PPA-Kupfer}}
	{{~~LinkWP_Miniartikel\|Txt=Hepatitis B\|Link=Hepatitis B~~}}